Loading clinical trials...
Loading clinical trials...
This study investigates the hypothesis that instability in mood in patients with borderline personality disorder will respond the mood stabilizing medication lamotrigine.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Mclean Hospital
Collaborators
NCT06458933 · Borderline Personality Disorder
NCT05712057 · Emotion Regulation, Mood Disorders, and more
NCT07342907 · Borderline Personality Disorder (BPD)
NCT05913544 · Borderline Personality Disorder
NCT07197502 · Borderline Personality Disorder, Borderline Personality, and more
McLean Hospital
Belmont, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions